Walgreens Boots Alliance (Nasdaq:WBA) - Hisse Senedi Fiyatı, Haberler ve Analizler

WBA Stoklara Genel Bakış

Walgreens Boots Alliance, Inc. sağlık, eczacılık ve perakende şirketi olarak Amerika Birleşik Devletleri, Almanya, Birleşik Krallık ve uluslararası alanda faaliyet göstermektedir. Daha fazla detay

WBA temel anali̇z
Kar Tanesi Skoru
Değerleme	5/6
Gelecekteki Büyüme	3/6
Geçmiş Performans	0/6
Finansal Sağlık	0/6
Temettüler	2/6

Ödüller

Adil değer tahminimizden 48.3% daha düşük bir oranda işlem görüyor

Kazançların yılda 106.56% oranında artması öngörülüyor

Rakiplerine ve sektöre kıyasla iyi değerde işlem görüyor

Risk Analizi

Faiz ödemeleri kazançlarla iyi karşılanmıyor

12.14% temettüsü kazançlar veya serbest nakit akışları tarafından iyi karşılanmıyor

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WarrenAI

Based on Analyst Price Targets

Strategic Store Footprint And Brand Focus To Enhance Margins And Cash Flow

Key Takeaways Strategic focus on retail pharmacy strengths and store optimization is aimed at stabilizing core economics and enhancing revenue growth. Initiatives on owned brand expansion and cost discipline target improved margins and operating income stability.

View narrative

US$10.81

23.8% undervalued

1.38%

Revenue growth p.a.

Updated

Walgreens Boots Alliance, Inc. Rakipler

Guardian Pharmacy Services

NYSE:GRDN

US$1.4b

Albertsons Companies

NYSE:ACI

US$11.2b

BJ's Wholesale Club Holdings

NYSE:BJ

US$11.4b

Sprouts Farmers Market

NasdaqGS:SFM

US$14.3b

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Walgreens Boots Alliance
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	US$8.24
52 Haftanın En Yüksek Seviyesi	US$27.05
52 Haftanın En Düşük Seviyesi	US$8.11
Beta	0.67
11 Aylık Değişim	-21.15%
3 Aylık Değişim	-17.85%
1 Yıllık Değişim	-60.17%
33 Yıllık Değişim	-82.33%
5 Yıllık Değişim	-86.29%
Halka arzdan bu yana değişim	2,472.48%

Son Haberler & Güncellemeler

Walgreens: 11.9% Dividend Yield Still On Unsteady Legs

Nov 18

Walgreens Q4: 2 Signs Of A Dividend Trap

Oct 29

Walgreens: Undervalued Pharma Giant Poised For A Turnaround Amid Cost-Cutting And Activist Investor Potential

Oct 23

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Oct 17

Recent updates

Walgreens: 11.9% Dividend Yield Still On Unsteady Legs

Nov 18

Walgreens Q4: 2 Signs Of A Dividend Trap

Oct 29

Walgreens: Undervalued Pharma Giant Poised For A Turnaround Amid Cost-Cutting And Activist Investor Potential

Oct 23

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Oct 17

Walgreens Boots Alliance: Likely A Value Trap, But Could Be A Speculative Long-Term Play

Aug 13

Walgreens: A Painful Turnaround Lesson

Aug 02

Walgreens: Here's What Comes Next

Jul 09

Walgreens: Yielding Over 8% Following The Earnings Drop

Jul 02

Walgreens: Beware The Value Trap Ahead Of Earnings

Jun 24

Walgreens: Another Dividend Cut Could Be Coming Soon (Rating Downgrade)

May 30

5 Reasons Walgreens Fell By 6.4% To Nearly 25-Year Lows

May 22

Walgreens: Hold Tight, Let It Turn Around First

May 06

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

May 05

3 Reasons Walgreens Can See Upside (Rating Upgrade)

Apr 10

Investors Still Waiting For A Pull Back In Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Apr 08

Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed

Apr 04

Walgreens Earnings Preview: Revenue Estimates Holding Up; It's A Cost Structure Problem

Mar 27

Walgreens' Strategic Pivot

Mar 21

Walgreens Q2, Dow Exit, And Bet Against Wall Street

Mar 15

Walgreens: New CEO Looking To Right The Ship

Feb 13

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

Jan 19

Walgreens Boots Alliance: Income Opportunity After Dividend Cut

Jan 17

Walgreens Q1: Dividend Cut Now What? (Rating Upgrade)

Jan 10

After Leaping 26% Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Are Not Flying Under The Radar

Dec 24

Walgreens Boots Alliance's (NASDAQ:WBA) Dividend Will Be $0.48

Oct 31

Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet

Oct 02

Hissedar Getirileri

	WBA	US Consumer Retailing	US Pazar
7D	-8.7%	-1.0%	-1.0%
1Y	-60.2%	45.0%	30.3%

Getiri vs. Endüstri: WBA geçen yıl % 45 oranında getiri sağlayan US Consumer Retailing sektörünün gerisinde kaldı.

Getiri vs Piyasa: WBA geçen yıl % 30.3 oranında getiri sağlayan US Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is WBA's price volatile compared to industry and market?
WBA volatility
WBA Average Weekly Movement	7.7%
Consumer Retailing Industry Average Movement	6.7%
Market Average Movement	6.2%
10% most volatile stocks in US Market	15.7%
10% least volatile stocks in US Market	3.1%

İstikrarlı Hisse Senedi Fiyatı: WBA son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: WBA 'nin haftalık oynaklığı ( 8% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
1909	252,500	Tim Wentworth	www.walgreensbootsalliance.com

Walgreens Boots Alliance, Inc. Amerika Birleşik Devletleri, Almanya, Birleşik Krallık ve uluslararası alanda sağlık hizmetleri, eczane ve perakende şirketi olarak faaliyet göstermektedir. Üç segment üzerinden faaliyet göstermektedir: ABD Perakende Eczacılık, Uluslararası ve ABD Sağlık Hizmetleri. ABD Perakende Eczacılık segmenti, sağlık ve zindelik, güzellik, kişisel bakım ve sarf malzemeleri ve genel ticari ürünler sunan perakende eczaneler, sağlık ve zindelik hizmetleri, özel ve eve teslim eczane hizmetlerinin işletilmesiyle ilgilenmektedir.

Walgreens Boots Alliance, Inc. Temel Bilgiler Özeti

Walgreens Boots Alliance'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
WBA temel i̇stati̇sti̇kler
Piyasa değeri	US$7.17b
Kazançlar(TTM)	-US$8.64b
Gelir(TTM)	US$147.66b

0.0x

P/S Oranı

-0.8x

F/K Oranı

WBA aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
WBA gelir tablosu (TTM)
Gelir	US$147.66b
Gelir Maliyeti	US$121.13b
Brüt Kâr	US$26.52b
Diğer Giderler	US$35.16b
Kazançlar	-US$8.64b

Son Raporlanan Kazançlar

Aug 31, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)	-9.99
Brüt Marj	17.96%
Net Kâr Marjı	-5.85%
Borç/Özkaynak Oranı	78.4%

WBA uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

Temettüler

12.1%

Mevcut Temettü Verimi

-12%

Ödeme Oranı

WBA güvenilir bir temettü ödüyor mu?

WBA temettü geçmişine ve kıyaslamalara bakın

Yaklaşan bir temettüyü almak için ne zaman WBA satın almanız gerekir?
Walgreens Boots Alliance temettü tari̇hleri̇
Eski Temettü Tarihi	Nov 18 2024
Temettü Ödeme Tarihi	Dec 12 2024
Eski temettüye kadar geçen günler	3 days
Temettü ödeme tarihine kadar geçen günler	21 days

WBA güvenilir bir temettü ödüyor mu?

WBA temettü geçmişine ve kıyaslamalara bakın

WBA Stoklara Genel Bakış

Ödüller

Risk Analizi

Strategic Store Footprint And Brand Focus To Enhance Margins And Cash Flow

Walgreens Boots Alliance, Inc. Rakipler

NYSE:GRDN

US$1.4b

NYSE:ACI

US$11.2b

NYSE:BJ

US$11.4b

NasdaqGS:SFM

US$14.3b

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

Walgreens: 11.9% Dividend Yield Still On Unsteady Legs

Walgreens Q4: 2 Signs Of A Dividend Trap

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on December 12, 2024

Walgreens: Undervalued Pharma Giant Poised For A Turnaround Amid Cost-Cutting And Activist Investor Potential

Walgreens Boots Alliance, Inc. Expects to Close Approximately 1,200 Stores over the Next 3 Years with About 500 Targeted to Close in Fiscal 2025

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Recent updates

Walgreens: 11.9% Dividend Yield Still On Unsteady Legs

Walgreens Q4: 2 Signs Of A Dividend Trap

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on December 12, 2024

Walgreens: Undervalued Pharma Giant Poised For A Turnaround Amid Cost-Cutting And Activist Investor Potential

Walgreens Boots Alliance, Inc. Expects to Close Approximately 1,200 Stores over the Next 3 Years with About 500 Targeted to Close in Fiscal 2025

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Walgreens: A Turnaround Stock To Avoid

Walgreens Boots Alliance, Inc. Provides Earnings Guidance for the Fiscal Year 2025

Price target decreased by 7.5% to US$11.33

Price target decreased by 7.8% to US$11.46

Walgreens Appoints Jason Stenta as SVP and Chief Commercial Officer

Walgreens Stock: Cheap At 3x FWD P/E, But Still Not Worth Buying

Saxena White P.A. Files New Securities Fraud Class Action Lawsuit Against Walgreens Boots Alliance, Inc. and Certain of its Executives

Price target decreased by 8.7% to US$12.43

Walgreens Boots Alliance, Inc. to Report Q4, 2024 Results on Oct 15, 2024

Is Walgreens Boots Alliance (NASDAQ:WBA) A Risky Investment?

Walgreens: Short Interest Surge Indicates It's Time To Cut Your Losses

Is Walgreens Ready To Rebound?

Walgreens Announces Executive Appointments

Upcoming dividend of US$0.25 per share

Walgreens Boots Alliance: Likely A Value Trap, But Could Be A Speculative Long-Term Play

Walgreens: A Painful Turnaround Lesson

Gross Law Firm Announces Lawsuit Against Walgreens Boots Alliance, Inc

Third quarter dividend of US$0.25 announced

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on September 12, 2024

Walgreens: Here's What Comes Next

Walgreens: Yielding Over 8% Following The Earnings Drop

Boots Chief Quits Reportedly After Walgreens' Sale Plan Stalls

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target decreased by 9.0% to US$20.21

Consensus EPS estimates fall by 41%

Walgreens: Beware The Value Trap Ahead Of Earnings

Walgreens Boots Alliance, Inc. to Report Q3, 2024 Results on Jun 27, 2024

Walgreens: Another Dividend Cut Could Be Coming Soon (Rating Downgrade)

5 Reasons Walgreens Fell By 6.4% To Nearly 25-Year Lows

Walgreens Announces Launch of Walgreens Brand Naloxone HCI Nasal Spray

Walgreens Reportedly Contacts Potential Buyers for £7 Billion Boots Drugstore Chain

Upcoming dividend of US$0.25 per share

Walgreens: Hold Tight, Let It Turn Around First

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

Second quarter dividend of US$0.25 announced

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on June 12, 2024

3 Reasons Walgreens Can See Upside (Rating Upgrade)

Investors Still Waiting For A Pull Back In Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed

New major risk - Financial position

Consensus EPS estimates fall by 11%

Walgreens Earnings Preview: Revenue Estimates Holding Up; It's A Cost Structure Problem

Walgreens' Strategic Pivot

Consensus EPS estimates increase by 11%

Walgreens Q2, Dow Exit, And Bet Against Wall Street

Wisner Baum Files Multiple Class Actions Alleging Several Companies Sold Benzoyl Peroxide Acne Products Without Warning Consumers That They Contain Unsafe Levels of Benzene, a Potent Human Carcinogen

Walgreens Boots Alliance, Inc. to Report Q2, 2024 Results on Mar 28, 2024

Walgreens Boots Alliance, Inc. Names Lanesha Minnix as Executive Vice President and Global Chief Legal Officer

Consensus EPS estimates fall by 14%

Walgreens: New CEO Looking To Right The Ship

Walgreens Boots Alliance, Inc. Announces Executive Changes